Skip to main content
digital therapeutics
Incorporating Xealth’s digital health platform with clinician recommendations also showed an increase of 2.5x in patient engagement rates.

Health System Results Reinforce Importance of Provider-Patient Relationship with Digital Health Programs


DTx programs show promise for improving outcomes across numerous medical conditions. Welldoc wanted to determine the best prescribing workflow to optimize patient engagement and adherence for its BlueStar digital therapeutic for managing diabetes.


With distribution enabled by Xealth, Welldoc discovered that engagement can be four times higher when sent direct to the patient from their care team. Xealth, which integrated the BlueStar solution into the EHR workflow, simplified the process of connecting patients with their healthcare team.

The Xealth integration facilitates one-click on-boarding and provides real-time data within the EHR system, delivering a patient’s data-driven insights to their provider to make the right interventions at the right time. When providers are connected to their patients, as demonstrated in a Welldoc randomized controlled trial, providers are 2-4x more likely to change an individual’s treatment plan to positively impact health in a timelier manner.

Results from multiple, nationally recognized health systems also show that patient engagement rates, a measure of how often patients engage with the program, double when BlueStar is recommended by a medical provider. Incorporating Xealth’s digital health platform with clinician recommendation also showed an increase by 2.5x in patient engagement rates as compared to a direct-to-consumer approach.

Back to Digital Therapeutics & PDTs Client Stories
Close Menu